🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prevention of Chronic Postsurgical Pain in Chronic Opioid Users:

RecruitingNAAges 18 Years - anyAllCentre Hospitalier Universitaire, Amiens
NCT07717151 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Chronic opioid users undergoing surgery are at increased risk of CPSP, contributing to long-term disability, decreased quality of life, and prolonged opioid exposure. Existing preventive strategies remain limited, and early postoperative monitoring may represent a key opportunity for intervention. Evidence suggests that transitional pain services can improve outcomes by optimizing pain control and reducing long-term opioid consumption, but implementation is heterogeneous and often resource-intensive. Telemedicine offers a scalable alternative, enabling early specialized evaluation and timely therapeutic adjustments while maintaining accessibility. This randomized controlled trial will compare standard postoperative follow-up with standard follow-up plus a specialized teleconsultation performed between postoperative day 15 and 28. The intervention aims to detect insufficiently controlled

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥18 years * Elective non-urgent surgery with expected moderate or higher postoperative pain * Chronic preoperative opioid use * Written informed consent * affiliated with a national social security scheme Exclusion Criteria: * Ambulatory surgery * Endoscopic or palliative surgery * Patients receiving opioid substitution therapy * Non-medical opioid use * Intrathecal/epidural analgesia or implanted neurostimulator * Legally protected adults * Severe psychiatric or neurodegenerative disorders
💊

What it tests

  • standard institutional perioperative management
  • specialized teleconsultation
📍

Where

1 site
CHU Amiens-Picardie
Amiens, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy